Saturday, May 28, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

clinical

Vacunas cubanas Abdala y Mambisa
Vacunas cubanas Abdala y Mambisa
Havana, nov 3 (Prensa Latina) Clinical trial Phase II with 'Abdala' and vaccine candidate 'Mambisa' for convalescents from Covid-19 in Cuba began here today, and included allergic people to thiomersal.
Havana, Aug 24 (Prensa Latina) Children from three to 11 years old received on Tuesday the last dose of the immunization scheme against Covid-19 approved for the Soberana Pediatric clinical trial, with the Soberana Plus vaccine, a Cuban booster proposal.